16:09 EDT Atossa Therapeutics files $100M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATOS:
- Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Atossa Therapeutics announce support of new breast cancer screening guidelines
- Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
- Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
- Atossa announces expanded research agreement with Weill Cornell Medicine